Tradestie Institutional Equity Comparison Engine
CAMP vs SGMT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGMT Overall Edge
SGMT Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sagimet Biosciences Inc. Series A Common Stock (SGMT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus SGMT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SGMT sits in BREAKOUT (5th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CAMP N/M vs SGMT N/M Fwd P/E
Growth & Margin Winner
SGMT
Op Margin -991.8% vs 0.0% ยท YoY +138.9% vs +0.0%
Momentum & Technical Winner
SGMT
1Y -3.7% vs +25.6% ยท 52W Pos 22% vs 75%
Options & Structure Winner
SGMT
UNCLASSIFIED (N/A IV) vs BREAKOUT (5th %ile IV)
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap
$238.5M
1M Return
+25.8%
1Y Return
-3.66%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
SGMT
NASDAQ
Sagimet Biosciences Inc. Series A Common Stock
Pharmaceutical Preparations
$9.73
-3.95% 1D
Market Cap
$735.2M
1M Return
+9.82%
1Y Return
+25.55%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 36.0
Fund 54.0
Flow 69.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAMP -3.66%
SGMT +25.55%
Spread: +29.21 pp (SGMT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAMP Revenue | SGMT Revenue | CAMP Op. Margin | SGMT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2023 | $0M | $0M | -14822.6% | -1537.0% | SGMT |
| FY2024 | $0M | N/A | -8142.3% | N/A | CAMP |
| FY2025 | $0M | N/A | -1502.4% | N/A | CAMP |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAMP | SGMT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.5M | $735.2M | Larger Scale | SGMT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +138.9% | +0.0% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | -991.8% | 0.0% | Higher Margin | SGMT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -146.1% | -29.5% | Higher ROE | SGMT |
| 52-Week Range Position Momentum | 22% ($3โ$8) | 75% ($4โ$11) | Stronger Trend | SGMT |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 94% Vol | 2.06ฮฒ ยท 83% Vol | Lower Realized Risk | SGMT |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 52.6 / 100 (HOLD) | Higher Composite | SGMT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAMP vs SGMT Buy Guide
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SGMT
BREAKOUT
141d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAMP nor SGMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.